# PTH Comparison in Post Menopausal Women

> **NCT00543218** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 63 (actual)

## Conditions studied

- Osteoporosis, Post-Menopausal

## Interventions

- **DRUG:** teriparatide 20 micrograms/day subcutaneous
- **DRUG:** calcitonin 100 IU/day subcutaneous

## Key facts

- **NCT ID:** NCT00543218
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** —
- **Final completion:** 2004-06
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2007-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00543218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00543218, "PTH Comparison in Post Menopausal Women". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00543218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*